BTG Pactual Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$7.11M 46
2022
Q3
$7.11M Buy
+100,000
New +$7.25M 1.86% 15
2022
Q2
Sell
-13,400
Closed -$979K 117
2022
Q1
$979K Buy
+13,400
New +$900K 0.13% 100
2020
Q1
Sell
-75,000
Closed -$4.78M 112
2019
Q4
$4.78M Sell
75,000
-75,000
-50% -$4.3M 0.78% 27
2019
Q3
$7.61M Buy
+150,000
New +$7.05M 3.39% 10
2019
Q2
Sell
-68,000
Closed -$3.24M 68
2019
Q1
$3.24M Buy
+68,000
New +$3.39M 1.24% 15

Other funds holding BMY

BTG Pactual Global Asset Management's BMY Position: Q3 2014 in Review

BTG Pactual Global Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2014, closing a stake of 48,250 shares — an estimated $2.34M sold.

BTG Pactual Global Asset Management first reported a position in BMY in Q4 2013 and held it in 3 quarters. The position peaked at $2.34M in Q2 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

  • BTG Pactual Global Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2014 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 48,250 Bristol-Myers Squibb shares in Q3 2014, an estimated $2.34M.
  • BTG Pactual Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 3 quarters.
  • BTG Pactual Global Asset Management's Bristol-Myers Squibb position peaked at $2.34M in Q2 2014.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.